CN Patent

CN116211833A — 一种咪唑立宾口腔速溶膜剂及其制备方法

Assigned to Nanjing Hicin Pharmaceutical Co ltd · Expires 2023-06-06 · 3y expired

What this patent protects

本发明提供一种3D打印咪唑立宾口腔速溶膜剂及其制备方法，该膜剂色泽一致，厚度均匀，性质稳定，接触口腔内唾液后能快速崩解溶出，起效迅速，避免了药物在胃肠道中降解，无首过效应，提高了体内生物利用度和药物安全性。便于患者自由选择(空腹和餐后)服药时间，极大的改善了患者的顺应性；同时还可根据患者的需求个性化定制剂量。

USPTO Abstract

本发明提供一种3D打印咪唑立宾口腔速溶膜剂及其制备方法，该膜剂色泽一致，厚度均匀，性质稳定，接触口腔内唾液后能快速崩解溶出，起效迅速，避免了药物在胃肠道中降解，无首过效应，提高了体内生物利用度和药物安全性。便于患者自由选择(空腹和餐后)服药时间，极大的改善了患者的顺应性；同时还可根据患者的需求个性化定制剂量。

Drugs covered by this patent

Patent Metadata

Patent number
CN116211833A
Jurisdiction
CN
Classification
—
Expires
2023-06-06
Drug substance claim
No
Drug product claim
No
Assignee
Nanjing Hicin Pharmaceutical Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.